Results 201 to 210 of about 143,069 (349)

Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on patient consent and shared decision‐making for blood transfusion

British Journal of Haematology, EarlyView.
The key points to be discussed with a patient when obtaining consent to transfusion are the reason for the transfusion, the benefits and risks of transfusion, the possible alternatives to transfusion, the process for transfusion, any specific transfusion requirements that the patient may have, the consequences of refusing transfusion and the ability to
Michael F. Murphy, Damien Carson, Anwen Davies, Stephanie Ditcham, Graham Donald, Roger Graham, Lizzie Hutchinson, Paul Kerr, Denise McKeown, John Moppett, Shruthi Narayan, Paolo Polzella, Ella Poppitt, Megan Rowley, Tracey Shackleton, Julie Staves, James Neuberger   +16 more
wiley   +1 more source

Diagnostic and Prognostic Significance of the Prothrombin Time/International Normalized Ratio in Sepsis and Septic Shock. [PDF]

Clin Appl Thromb Hemost, 2022
Schupp T, Weidner K, Rusnak J, Jawhar S, Forner J, Dulatahu F, Brück LM, Hoffmann U, Bertsch T, Müller J, Weiß C, Akin I, Behnes M.   +12 more
europepmc   +1 more source

Impact of Lupus Anticoagulant on INR Using Recombinant Prothrombin Time Reagent. [PDF]

Am J Case Rep
Kamal F, Othman HR.
europepmc   +1 more source

Case report of recurrent bleeding in an infant with isolated prolonged prothrombin time due to congenital factor VII deficiency---a riddle solved. [PDF]

J Family Med Prim Care, 2022
Ganguly M, Sutradhar S, Rajbangshi A, Pattnaik A, Maiti D.   +4 more
europepmc   +1 more source

Prognostic value of prothrombin time and activated partial thromboplastin time in patients with posttraumatic disseminated intravascular coagulation.

, 1994
Satoshi Gando, Satoshi Nanzaki, Takashi Kameue, Hiroshi Makise, Yoshimi Nakanishi   +4 more
openalex   +2 more sources

Impact of Age, CYP2C9 Genotype and Concomitant Medication on the Rate of Rise for Prothrombin Time During the First 30 Days of Warfarin Therapy [PDF]

, 2005
Russell A. Wilke, Richard L. Berg, Humberto Vidaillet, Michael D. Caldwell, J. K. Burmester, Michael A Hillman   +5 more
openalex   +1 more source

Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL‐4, Enhancing Tumor Growth in Hepatocellular Carcinoma

Cancer Science, EarlyView.
Tumor endothelial cells (TECs) promote the polarization of macrophages to M2 subtype by secreting IL‐4. Downregulation of IL‐4 in TECs suppressed M2 polarization and tumor progression. A high abundance of both TECs and M2 macrophages in HCC specimens is associated with poor prognosis.
Daijiro Matoba, Takehiro Noda, Shogo Kobayashi, Yoshihiro Sakano, Kenichi Matsumoto, Chihiro Yamanaka, Kazuki Sasaki, Shinichiro Hasegawa, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Hidenori Takahashi, Tadafumi Asaoka, Junzo Shimizu, Hisashi Wada, Yuichiro Doki, Hidetoshi Eguchi   +17 more
wiley   +1 more source

Fully printed prothrombin time sensor for point-of-care testing. [PDF]

Biosens Bioelectron, 2021
Williams NX, Carroll B, Noyce SG, Hobbie HA, Joh DY, Rogers JG, Franklin AD.   +6 more
europepmc   +1 more source

Aprotinin Prolongs Whole Blood Activated Partial Thromboplastin Time but Not Whole Blood Prothrombin Time in Patients Undergoing Cardiac Surgery

, 1995
George J. Despotis, Alexander Alsoufiev, Lawrence T. Goodnough, Demetrios G. Lappas   +3 more
openalex   +1 more source

Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy [PDF]

, 2005
Johanna HH. van Geest-Daalderop, André B. Mulder, Leandra JM Boonman-de Winter, Martha M.C.L. Hoekstra, Anton MHP van den Besselaar   +4 more
openalex   +1 more source